Printer Friendly

MEDICAL DEVICES, INC. ANNOUNCES EXERCISE OF 100 PERCENT OF OUTSTANDING WARRANTS

 ST. PAUL, Minn., Feb. 11 /PRNewswire/ -- Medical Devices, Inc. (NASDAQ: MDEV) (MDI) announced today that the company has received a total of $420,000 in new funds as a result of the exercise of 420,000 warrants to purchase common stock at $1.00 per share.
 The warrants were originally issued in conjunction with the company's $504,000 equity private placement in November of 1992. The company called for the redemption of the warrants in January of 1993. All of the outstanding warrants were exercised. The common stock issued for these warrants are restricted shares, and bring MDI's total outstanding shares to 3,348,938.
 "This additional infusion of funds, so soon after the original cash infusion, will allow us to more aggressively expand our direct marketing efforts through Rehabilicare Systems (TM)," according to David B. Kaysen, president and CEO. Kaysen also stated, "We plan to use these funds to invest in inventories and expansion of sales and marketing for Rehabilicare Systems, continue to build upon the momentum we have begun in the first six months of this fiscal year."
 Medical Devices, Inc. is a leading designer and manufacturer of electromedical rehabilitation and pain management products. The company's common stock is traded on the national over-the-counter market under the NASDAQ symbol "MDEV."
 -0- 2/11/93
 /CONTACT: David B. Kaysen, president and CEO or Jeffrey P. Shields, vice president of finance, both of Medical Devices, 612-631-0590/
 (MDEV)


CO: Medical Devices, Inc. ST: Minnesota IN: MTC SU:

DS -- MN039 -- 5824 02/11/93 15:34 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 11, 1993
Words:255
Previous Article:ION LASER TECHNOLOGY FILES FOR FDA CLEARANCE OF CURING LASER
Next Article:MESABA REPORTS JANUARY TRAFFIC
Topics:


Related Articles
MEDICAL DEVICES, INC. ANNOUNCES COMPLETION OF EQUITY PRIVATE PLACEMENT
MEDICAL DEVICES, INC. CALLS WARRANTS FROM PRIVATE PLACEMENT
SCHERER HEALTHCARE/MARQUEST MEDICAL FINANCING COMPLETED
SCHERER HEALTHCARE/MARQUEST MEDICAL FINANCING COMPLETED
BIOSOURCE INTERNATIONAL WARRANT HOLDERS PURCHASE 268,000 SHARES OF STOCK
MARQUEST MEDICAL PRODUCTS FINANCIAL RESTRUCTURING PROGRESS
DALTEX MEDICAL SCIENCES, INC. REDUCES THE EXERCISE PRICES AND EXTENDS THE EXPIRATION DATES OF ITS CLASS A AND CLASS B WARRANTS
DALTEX MEDICAL SCIENCES, INC. EXTENDS THE EXPIRATION DATES OF ITS CLASS A AND CLASS B WARRANTS
DALTEX MEDICAL SCIENCES, INC. EXTENDS THE EXPIRATION DATES OF ITS CLASS A AND CLASS B WARRANTS
STI/BBC Merger Creates New Medical Device Company 'Meridian Medical Technologies'

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters